Gene · 6607
NIH grants1,484
NIH grants whose papers are about the gene, through NIH's grant-paper links.
361 to 380 of 1,484
Download this page as JSON| Grant | Title | SMN2 papers | Newest fiscal year |
|---|---|---|---|
| R01AR060733 | Transcriptome processing networks in skeletal muscle: mechanisms and functions | 2 | 2023 |
| R01DC017117 | Enhanced gene delivery for CNS and sensory disorders | 2 | 2023 |
| R01GM130866 | ALTERNATIVE SPLICING REGULATION AND MEMBRANE TRAFFICKING | 2 | 2023 |
| U01AG006786 | Alzheimers Disease Patient Registry | 2 | 2023 |
| U01CA253481 | Integrative genomic and epigenomic analysis of cancer using long read sequencing | 2 | 2023 |
| U01HG010961 | The construction and utility of reference pan-genome graphs | 2 | 2023 |
| K01DK116934 | Deregulation of Long Noncoding RNA in the Pathogenesis of Autosomal Dominant Polycystic Kidney Disease | 1 | 2023 |
| K08CA230319 | Defining the Biological and Mechanistic Implications of XPO1 Mutations in Hematologic Malignancies | 1 | 2023 |
| K08HL146990 | Precision Medicine for Heart Failure: The Role of Genomics in the Efficacy and Racial Disparity of Cornerstone Pharmacotherapy | 1 | 2023 |
| K08HL146991 | Therapeutic Applications of Factor VIIIa Inactivation in Hemophilia A | 1 | 2023 |
| K24AG045333 | Multimodal Imaging in Frontotemporal Degeneration | 1 | 2023 |
| K99AG075238 | Elucidating sex-specific risk for Alzheimer's disease through state-of-the-art genetics and multi-omics | 1 | 2023 |
| P01AG017242 | DNA Repair, Mutations and Cellular Aging | 1 | 2023 |
| P01HL146372 | Targeting Enzymatic Regulation of Fetal Hemoglobin Repression | 1 | 2023 |
| P20AG068082 | Vanderbilt Alzheimer's Disease Research Center | 1 | 2023 |
| R01AG061155 | Somatotropic Signaling and Resilience to Aging and Alzheimer's Disease | 1 | 2023 |
| R01AR073908 | Alternative delivery of adeno-associated virus therapeutic vector for the treatment of neuromuscular disorders | 1 | 2023 |
| R01CA229696 | Role of UHRF1 in osteosarcoma and its relationship to RB | 1 | 2023 |
| R01CA233201 | An improved IL-24 gene-based therapeutic for cancer | 1 | 2023 |
| R01CA240984 | An antisense RNA-mediated regulatory program that drives cancer metastasis | 1 | 2023 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6607/grants?page=19